tirzepatide shortage compound FDA Allows Compounded During Review FDA Affirms Decision on Tirzepatide

But remember, the most reliable number is always the one printed on your specific product by the manufacturer or compounding pharmacy

The change in BMI and utility parameters were varied by 25% of their base-case value

[DOI] [PubMed] [Google Scholar] 87.Marty VN, Farokhnia M, Munier JJ, Mulpuri Y, Leggio L, Spigelman I

Originally used for treating type 2 diabetes, Tirzepatide has become increasingly popular in medical weight management as it is highly effective in promoting significant weight loss, making it a promising option for individuals struggling with obesity

Notably, Zepbound is the first GLP-1 drug to be approved for obesity

FDA clarifies policies as national GLP-1 supply begins to stabilize